Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 14/20 | 0.51 |
| ▸ | FEN1 | P39748 | 3/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.38 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.37 |
| ▸ | GCGR | P47871 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13378117 | 0.93 | FFAR4 (0.50) | FFAR4 | |
| SCHEMBL2888198 | 0.88 | FFAR4 (0.50) | FFAR4S1PR1S1PR3S1PR5GCGR | |
| SCHEMBL6700661 | 0.88 | FFAR4 (0.42) | FFAR4FEN1S1PR1S1PR3S1PR5 | |
| Hydrochloric Acid SCHEMBL2882694 | 0.88 | FFAR4 (0.49) | FFAR4S1PR1S1PR3S1PR5GCGR | |
| SCHEMBL6701875 | 0.85 | PPARD (0.45) | FFAR4FEN1S1PR3S1PR5 | |
| SCHEMBL13378123 | 0.85 | MRGPRX4 (0.46) | FFAR4 | |
| SCHEMBL13009866 | 0.85 | FEN1 (0.49) | FFAR4FEN1 | |
| SCHEMBL13009739 | 0.85 | PTGER1 (0.48) | FFAR4 | |
| SCHEMBL4650113 | 0.82 | FFAR4 (0.62) | FFAR4 | |
| SCHEMBL2995595 | 0.80 | FFAR4 (0.50) | FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040176446-A1 | Substituted amino dicarboxylic acid derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176446-A1 | Substituted amino dicarboxylic acid derivatives | BCAT2, BCAT1, AADAT | FFAR4 749/4885FEN1 3524/4885S1PR1 4456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.